INTERNATIONAL PATENT: VANDERBILT UNIVERSITY FILES APPLICATION FOR "HUMAN ANTIBODIES TO CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS"

GENEVA, Feb. 18 -- VANDERBILT UNIVERSITY (305 Kirkland Hall2201 West End AvenueNashville, Tennessee 37240) filed a patent application (PCT/US2025/041309) for "HUMAN ANTIBODIES TO CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS" on Aug 08, 2025. With publication no. WO/2026/036058, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CROWE, James E. (2101 20th Avenue SouthNashville, Tennessee 37212)

Abstract: The present disclosure is directed to antibodies binding to and neutralizing Crimean Congo Hemorrhagic Fever Virus and methods fo...